Reflexão sobre o ensino farmacêutico

This paper aims to discuss the directions of pharmaceutical education based on the new curriculum guidelines from MEC (Ministry of Education - Brazil). In the recent past, Brazilian pharmaceutical faculties prioritized the formation of professional resources in specific modalities in detriment of pharmacist's private field: the prescription filling and delivery at the drugstore. In order to avoid repeating the same mistake it is necessary to develop new competence, allowing the graduates to develop skills to connect the scientific and technological knowledge to Brazilian social context. The new curriculum guidelines are about to finish a time when the undergraduate studies seemed to split the pharmacist into two different professionals: one for the clinical analysis and other for the pharmaceutical industry. The previous educational model, which supposedly allows for pharmaceutical care without providing a broad integral knowledge of health sciences, cannot be repeated in the new curriculum. However, teaching subjects in a superficial and segmented manner, replete of predictable and repetitive technical practices and without a skilled teaching staff, will give no improvement in pharmacists education care. It is clear that the return of the formation of specific human resources in the field won't happen in short time.

Gestão de desvios técnicos no recebimento de medicamentos na Central de Abastecimento Farmacêutico

Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB

Schinus Terebinthifolius Raddi: estudo anatômico e histoquímico das folhas e investigação do potencial farmacêutico do extrato etanólico e suas frações

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Desenvolvimento de sensor biomimético para determinação de captopril em amostras de interesse ambiental, biológico e farmacêutico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Desenvolvimento e validação de metodologia analítica e estudo de estabilidade de tigeciclina em produto farmacêutico

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

O farmacêutico em oncologia: o que temos, podemos e fazemos

Com os avanços em oncologia, os profissionais de saúde despertaram para o fato de que cuidar de um portador de um câncer requer uma abordagem interdisciplinar, que proporciona a assistência integral, de forma a compreender o paciente em múltiplos domínios, tendo como preocupação fundamental a preservação da sua qualidade de vida. A ação do farmacêutico é parte fundamental desse cuidado ao paciente, para garantir a qualidade e a segurança da terapia em quaisquer das etapas da doença. Para tanto, este profissional deve mostrar profundo conhecimento na área de farmácia clínica em oncologia, atenção farmacêutica e ações relativas à promoção e recuperação da saúde, o que demanda formação técnica de excelência e desenvolvimento de competências comportamentais. . Deste modo, o trabalho de conclusão de curso intitulado O farmacêutico em oncologia – o que temos, podemos e fazemos teve por objetivo buscar na literatura especializada quais são os requisitos para se formar tal especialista, quais são os dispositivos legais que regem sua atuação, as suas atribuições técnicas, sobretudo, o como e o quê sua atuação gera. Os estudos realizados por diversos autores evidenciaram a importância da atenção farmacêutica no setor oncológico, na prevenção de erros de medicação pela revisão das prescrições médicas, contorno dos resultados negativos associados aos medicamentos, o que refletiu na economia dos gastos hospitalares, caracterizando um processo positivo de farmacoeconomia, em que seu sucesso leva à melhora da qualidade de vida para o paciente.

Análise da implantação do TPM em uma empresa do ramo farmacêutico

Through observation of the production process industries today, one can encounter the needs of the large uncertainties related improvements and changes in the production environment, a fact that inspired the search for solutions that can respond quickly to these changes. Thus, this paper describes the review of implementation of TPM (total productivity management), which aims to optimize two distinct processes in the Vale do Paraíba´s pharmaceutical industry one of through the pillar of specific improvement. The main objective is to propose an efficient alternative to proposing loss management processes by identifying and eliminating the same in a systematic process. To develop this analysis was necessary to explore concepts of TPM and tools that help in taking data, identification and clarification of the phenomena that cause failures in the process, which were essential to ensure the development of the analysis. The concepts covered are usually presented during an undergraduate degree in Engineering. Data compiled by the analysis are able to serve as a strategic benchmark for decision making by managers, providing alternative response variables and uncertainty of the organizational environment, a fact that facilitates the management of human resources and productive

Sobre a promoção da saúde na contemporaneidade: um desafio ao farmacêutico educador

Pós-graduação em Educação - IBRC

Análise envoltória de dados combinada com a lógica fuzzy em problemas de avaliação de eficiência de máquinas de consumo: um estudo em empresa do segmento farmacêutico

The pharmaceutical industry was consolidated in Brazil in the 1930s, and since then has become increasingly competitive. Therefore the implementation of the Toyota Production System, which aims to lean production, has become common among companies in the segment. The main efficiency indicator currently used is the Overall Equipment Effectiveness (OEE). This paper intends to, using the fuzzy model DEA-BCC, analyze the efficiency of the production lines of a pharmaceutical company in the Paraíba Valley, compare the values obtained by the model with those calculated by the OEE, identify the most sensitive machines to variation in the data input and develop a ranking of effectiveness between the consumer machinery. After the development, it is shown that the accuracy of the relationship between the two methods is approximately 57% and the line considered the most effective by the Toyota Production System is not the same as the one found by this paper

Consumo de medicamentos em região do Estado de São Paulo (Brasil), 1985

Com o objetivo de avaliar as características do consumo de medicamentos na população urbana de Araraquara, SP, Brasil, foram coletados dados, por meio de entrevistas domiciliares, de uma amostra da população que consumiu pelo menos um medicamento nos quinze dias que antecederam a data da entrevista. O estudo foi realizado no período de agosto a setembro de 1985. Verificou-se que 42,1% dos medicamentos utilizados foram adquiridos sem prescrição médica. O consumo entre o sexo feminino foi maior que para o sexo masculino. Na automedicação o grupo que apresentou taxa mais elevada, segundo a faixa etária, foi o de 50 anos e mais, com 31,6%. Grande parte do consumo de medicamentos constituiu-se dos industrializados (97,6%). As prescrições médicas, feitas em consultas anteriores, e avalia das como bem sucedidas foram retomadas em situações diversas (12,0%), revelando o importante papel que o médico desempenha na formação dos critérios de escolha dos remédios utilizados nas práticas de automedicação. O farmacêutico e/ou balconista de farmácia contribui com 10,0% dos medicamentos usados que tiveram essa via de indicação. As orientações feitas por amigos, vizinhos e parentes (9,1%) revelaram intenso circuito de trocas de socializações quanto aos quadros móbidos e indicações terapêuticas.

Assessment of pharmacotherapeutic safety of medical prescriptions for elderly residents in a long-term care facility

The present study aimed to estimate the prevalence of elderly using potentially inappropriate medications (PIM) and with occurrence of potentially hazardous drug interactions (PHDI), to identify the risk factors for the prescription of PIM and to evaluate the impact of pharmaceutical intervention (PI) for the prescription of safer therapeutic alternatives. Therefore, a cross-sectional study was performed in a long-term care facility in São Paulo State, between December/2010 and January/2011. The medical records of the patients >= 60 years old who took any drugs were consulted to assess the pharmacotherapeutic safety of the medical prescriptions, in order to identify PIM and PHDI, according to the Beers (2003) and World Health Organization criteria, respectively. PI consisted of a guidance letter to the physician responsible for the institution, with the suggestions of safer equivalent therapeutics. Approximately 88% of the elderly took at least one drug, and for 30% of them the PIM had been prescribed. Most of the PIM identified (53.4%) act on the central nervous system. Among the 13 different DI detected, 6 are considered PHDI. Polypharmacy was detected as a risk factor for PIM prescription. After the PI there was no change in medical prescriptions of patients who had been prescribed PIM or PHDI. The data suggests that PI performed by letter, as the only interventional, method was ineffective. To contribute it a wide dissemination of PIM and PHDI among prescriber professionals is necessary for the selection of safer treatment for elderly. Additionally, a pharmacist should be part of the health care team in order to help promote rational use of medicines.

Influência da granulometria de grânulos de amido sobre a densidade aparente de extratos atomizados

Starches and modified starch derivations are used as carriers in the spray drying processing where apparent density is an important characteristic and should be controlled in dehydrated products for pharmaceutical use. In Brazil, the commercial starches are made from corn and cassava, but there are others with potential for extraction. The canna and taro starches were selected because they represent the extremes of granule size and thus allow the effect of this size on the apparent density of spray dried products to be tested. For comparison, commercial cassava and corn starches which are used in spray-drying and have granules of intermediate size, were also tested. The spray-drying process was carried out with a LabPlant SD 04 Spray Dryer, operating at a pressure of 6 lb/in2, air of 7,6 mL/minute, and 1 cm atomizing nozzle. The air inlet temperature was set at 200°C this model does not allow regulating outlet temperature. The spray-dryer products had boldo leaf extract as base, using the four starches as carrier. The dry product was evaluated for humidity, water activity (Aw), granulometry and apparent density. The results showed that the size of the particles, which was a consequence of the size of the starch granules, influenced the apparent density of the spray dried products, which as higher (694, 27 g/mL) for the canna starch and lower (456, 13 g/mL) for taro starch. Corn and cassava starches showed very close and intermediate values, 521,51 and 58,48 g/mL, which also represent the standard range of starch granule size.

Intervenções farmacêuticas na atenção à saúde mental: Uma revisão

Uma revisão dirigida foi realizada nas bases de dados IBECS, LILACS e MEDLINE, até fevereiro/2011, para identificar intervenções farmacêuticas (IF) na atenção farmacêutica em saúde mental e os seus resultados. Para a busca utilizaram-se os descritores em saúde: Pharmaceutical Care, Pharmaceutical Services, Medication Adherence, Pharmacists, Mental Health, Mental Health Services, Mental Health Assistance, Community Mental Health Services, Mentally Ill Persons andMental Disorders. Identificaram-se 1686 publicações, das quais 21 contemplaram os critérios de inclusão. Após exploração do material, apenas cinco estudos tratavam-se de IF. Todos foram conduzidos no nível secundário de atenção, com abordagem individual, por meio do acompanhamento da terapia (3), intervenção educativa por cartas a médicos e pacientes (1), aconselhamento farmacêutico presencial e remoto e inserção de terapia com sistema transdérmico de nicotina (1). Os resultados, tais como promoção da adesão e resolução de problemas relacionados a medicamentos foram positivos para a terapêutica. No entanto, é necessário que as IF monitorem os parâmetros clínicos, as mudanças de hábitos, a melhora na qualidade de vida e os aspectos farmacoeconômicos a fim de avaliar os seus impactos. Palavras-chave:Atenção Farmacêutica. Assistência Farmacêutica. Adesão à Medicação. Farmacêuticos. Saúde Mental. ABSTRACT Pharmaceutical interventions in mental health services: a review A directed review was performed in IBECS, LILACS and MEDLINE databases, until February/2011, in order to identify the studies which developed pharmaceutical interventions (PI) in pharmaceutical care in mental health services and estimated their results. The search was carried out using the follow health science descriptors: Pharmaceutical Care, Pharmaceutical Services, Medication Adherence, Pharmacists, Mental Health, Mental Health Services, Mental Health Assistance, Community Mental Health Services, Mentally Ill Persons andMental Disorders. It was identified 1686 manuscripts, of whose 21 contemplated the inclusion criteria. After the content analysis of the eligible manuscripts, only five developed PI. All of them were conducted in the second level of health care, with individual approach, through: therapy follow-up (3), educational interventions by letters to physicians and patients (1), presence or remote pharmaceutical counseling and inclusion of therapy with nicotine transdermal patch (1). The data, such as adherence promotion and solving drug related problems, were positive for the therapeutic. However, it is necessary that the PI monitor the clinical parameters, the habit changes, the improvement in the quality of life and the pharmacoeconomic aspects, in order to assess their impacts. Keywords: Pharmaceutical Care. Pharmaceutical Services. Medication Adherence. Pharmacists. Mental Health. Mental Disorders.

Intervenções educativas com usuários de medicamentos como estratégias terapêuticas

A review and analysis of the literature on educative interventions (EI) for medicine users was carried out. For this purpose, databases were searched by employing descriptors related to pharmaceutical care, education and health, covering the period from 1997 to early 2011. A set of 21 articles related to EI with medicine users were selected, 18 (85.7%) of which referred to studies on basic health care. The EI most commonly reported in the articles were: talks, group discussions and educative material. The positive outcomes reported were: improvement in quality of life (better acceptance of the disease), economic advantages (reduction in number of medical consultations) and clinical improvement (risk reduction, prevention of complications).